This approach could transform radiation therapy by allowing higher doses to be used more safely, ultimately improving outcomes for cancer patients.

Healx has dosed the first patient in a Phase II trial assessing its lead pipeline candidate HLX-1502 in patients with neurofibromatosis type 1 (NF1), while the FDA approved SpringWorks Therapeutics’ ...

The scientists found that HSV-1 activates transposable elements that impact the accumulation of Alzheimer's-linked proteins ...

The AGBT meeting has begun in Marco Island, Florida and Julianna LeMieux is on the ground. Here, she shares the latest news ...

AI tool uses MRI scans to track the pace of brain changes, mapping anatomic variations in regional brain aging rates according to factors including sex and age.

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

Researchers say understanding how Zika virus spreads through the human placenta and reaches the fetus is critical to prevent ...

Roche introduces Sequencing by Expansion (SBX) technology in a webinar just a few days before the AGBT meeting takes place in ...

ISM001-055 was shown to have attenuated cellular senescence through the suppression of various aging processes, thus showing potential as a senomorphic drug.

MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.

Funding from Cancer Prevention and Research Institute of Texas has brought more than 324 distinguished cancer researchers to Texas.

The research advance represents a 1,000-fold improvement in speed and throughput in Brillouin microscopy, according to the ...